AQST Q2 2018 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$14M+25.0% YoY

Gross Profit

$9M64.3% margin

Operating Income

-$33M-234.7% margin

Net Income

-$36M-262.0% margin

EPS (Diluted)

$-1.52

QoQ Revenue Growth

-40.5%

Cash Flow

Operating Cash Flow

$511,000

Free Cash Flow

-$116,000

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$40M

Total Liabilities

$79M

Stockholders' Equity

-$39M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$11M	+25.0%
Gross Profit	$9M	$6M	+49.2%
Operating Income	-$33M	-$4M	-705.3%
Net Income	-$36M	-$6M	-518.8%

Revenue Segments

Manufacture and Supply Revenue

$9M92%

Co-Development and Research Fees

$712,0008%

Geographic Segments

United States

$13M100%